Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Rev. Soc. Colomb. Oftalmol ; 49(1): 24-31, 2016. tab. graf.
Article in Spanish | LILACS, COLNAL | ID: biblio-908948

ABSTRACT

Objetivos: Determinar el comportamiento de la coriorretinopatía serosa central (CSC) en los pacientes que asistieron a consulta a la clínica Oftalmológica de Cartagena en el periodo comprendido de julio del 2013 a julio de 2014. Diseño del estudio: Estudio observacional-descriptivo de tipo transversal. Métodos: Se revisaron las historias clínicas y los reportes de las ayudas diagnosticas Tomografía Óptica Coherente (OCT) y Angiografía Fluoresceínica (AF) de los pacientes diagnosticados con CSC en el periodo de Julio de 2013 a Julio de 2014 en la Clínica Oftalmológica de Cartagena. Resultados: 42 pacientes que cumplieron con todos los criterios; 9 pacientes diagnosticados con AF, 10 pacientes con OCT y 23 con diagnóstico confirmado por ambas ayudas diagnósticas. La condición es más frecuente en el sexo masculino, en edades entre los 30 y 39 años, casados con estudios bachilleres completos y en la raza negra. Según el test de ansiedad aplicado, en la muestra de pacientes no se encontró relación entre la ansiedad y la aparición de CSC. Conclusiones: El comportamiento de la CSC en la Clínica Oftalmológica de Cartagena fue similar al reportado por la literatura médica. Se recomienda realizar más estudios en los que se evalúe con mayor enfoque la asociación de la CSC y el nivel de ansiedad.


Objective: Determine the behavior of the central serous chorioretinopathy in patients seen at Clínica Oftalmológica de Cartagena in the period of July 2013 to July 2014. Design: Descriptive observational crosssectional study. Methods: Revision of medical records and reports of diagnostic exams (OCT and FA) of patients diagnosed with CSC in the period from July 2013 to July 2014. Results: 42 patients who met all the criteria; 9 patients with FA, 10 patients with OCT and 23 with a diagnosis confi rmed by both methods. The condition was more common in males, aged between 30 and 39 years old, married with complete high school studies, and in blacks. According to the test anxiety applied in the sample there was no relationship between anxiety and the appearance of CSC. Conclusions: Th e trend of the CSC at Clínica Oftalmológica de Cartagena was similar to that reported in medical literature. We recommend further studies that evaluated the association with major focus of the CSC and the level of anxiety.


Subject(s)
Central Serous Chorioretinopathy , Diagnostic Techniques, Ophthalmological , Fluorescein Angiography , Tomography, Optical Coherence
2.
Journal of the Korean Ophthalmological Society ; : 1419-1422, 2010.
Article in Korean | WPRIM | ID: wpr-220346

ABSTRACT

PURPOSE: To report a case of chronic central serous chorioretinopathy treated with an intravitreal injection of 2.5 mg of bevacizumab. CASE SUMMARY: A 38-year-old male complained of visual disturbance in the right eye. He had a history of central serous chorioretinopathy which improved without treatment. Since the patient did not feel any ocular discomfort, he did not visit our clinic for approximately 11 months. At the time of presentation, fundus examination revealed exudative retinal detachment involving the macular area. Additionally, fluorescein angiography revealed multiple early phase hyperfluorescent lesions. Neurosensory detachment around the macula and increased central macular thickness were also observed using optical coherence tomography. Under the diagnosis of chronic central serous chorioretinoapthy, the patient was treated with 2.5 mg of intravitreal bevacizumab. Visual acuity improved two months after treatment, with improvement in both neurosensory retinal detachment and fluorescein leakage. No changes were observed at the six-month follow-up.


Subject(s)
Adult , Humans , Male , Antibodies, Monoclonal, Humanized , Central Serous Chorioretinopathy , Eye , Fluorescein , Fluorescein Angiography , Follow-Up Studies , Intravitreal Injections , Retinal Detachment , Retinaldehyde , Tomography, Optical Coherence , Visual Acuity , Bevacizumab
SELECTION OF CITATIONS
SEARCH DETAIL